| Application no. and date | 10738119.6 (espacenet) (Federated) (European Patent Register), 20100726 | | Patent/reg. no. and date | DK/EP 2459224, 20160601 | | Publication date | 20120606 | | Priority no. and date | US 228828 P, 20090727, US 347136 P, 20100521 | | EP pub. no. and date |
EP 2459224 20120606 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku
Osaka-Shi, Osaka, JP | | Applicant ref. no. | P58987DK01 | | Inventor | TURECEK, Peter, Weidling
Hauptstrasse 59g
A-3400 Klosterneuburg, AT,
SIEKMANN, Juergen, Gerasdorfer Strasse 153/209
A-1210 Vienna, AT,
ROTTENSTEINER, Hanspeter, Haidgasse 10/17
A-1020 Vienna, AT,
HAIDER, Stefan, Mozartstrasse 2
A-3385 Prinzersdorf, AT | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 47/48 (2006.01) | | Title | BLODSTØRKNINGSPROTEINKONJUGATER | | Int. application no. | US2010043242 | | Int. publication no. | WO2011017055 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
